Distribute Kovid vaccine on voter list of election booths in Gujarat, what if politicians and officials black market?

Prime Minister,

Gandhinagar, 29 November 2020
The Government of Gujarat, after the approval of the Government of India, has started preparing a master plan for distribution of Corona vaccine to the people. A committee of secretaries of Health, Labor and Employment, Urban Development, Finance and other departments has been formed to work across the state on vaccine delivery methods. Vaccination will be given as per voter list. The problem, however, will be how to vaccinate children and citizens who are not registered to vote.

1 lakh Kovid stations

1 lakh Kovid stations will be made in place of polling stations and schools. Kovid vaccine will be given after vaccination with indestructible ink. So that no one takes it a second time. The indelible ink is manufactured by the Mysore Paints and Varnish Limited Company of the Government of Karnataka, a specialized ink formula developed by the National Physical Laboratory. Which does not dad last for 7 to 15 days of ink. 23% of the substance is silver nitrate. They have to prepare a total of 1 lakh small vials of 5.5 ml and 7.5 ml for polling stations. 350 people can be targeted with a bottle. The ink cost will be Rs 2 crore. 6.50 crore people of Gujarat will visit polling stations.

corruption in vaccination

However, it is a question whether the committee will take care to ensure that homeopathic carcinogenic drug is seized by the leaders and officials of Gandhinagar. Similarly, there are 1 crore members of the ruling party, one has to be careful to get vaccinated there. Because there is a full potential for widespread corruption in vaccination. So every stock has to be looked after.

Use of election booth system

A source in the secretariat said that the committee headed by the chief secretary recently held a meeting for the first time. Will meet once a week. For ordinary citizens, it has been decided to use the existing election booth system. Where all the details of voters like age, address and other details are available. Special booths will be created to vaccinate people on the basis of voter list.

Ink on nails

Ink will also be applied on the nails to identify the vaccine that has been vaccinated. The Collector has been asked to prepare a list of qualified government officials for the implementation of the vaccination program.

Who first

The vaccine will be given first to health workers, government officials, the elderly, and then to the general public. The central government has already announced to do so.

India’s three

Zydus Cadila Company based in Changodar has a plant in Ahmedabad, Gujarat. The therapeutic development of Zydo-D is a drug vaccine manufactured by Zydus Cadila. Zydus Cadila Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune are developing the vaccine.

Human trials in 6 cities

The process of developing an indigenous vaccine for the corona virus is moving very fast in India. India Biotech and Zydus Cadillac vaccine are undergoing human trials in 6 cities. A 30-year-old man was given 0.5 ml of intramuscular injection of kovixin manufactured by Bharat Biotech in AIIMS, Delhi on Friday. He was the first person from Delhi to be given this injection.

Both Bharat Biotech and Zedus Cadila were allowed the first and second stages of clinical trials. The first vaccine was given to corona candidates on 15 July 2020. On the other hand, the vaccine developed by Oxford University will soon be tested in India. The Serum Institute is an Indian company working with the United Kingdom pharma company AstraZeneca.

Bharat Biotech

Kovexin of Bharat Biotech has been developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The vaccine is being tested in 12 cities. The hospitals where it is being tested include AIIMS and PGI Rohtak in Delhi and Patna.

Zyds Developed Vaccine (JCOV-D)

The vaccine developed by Zyds (JCOV-D) is currently being tested at a research center in Ahmedabad, but will soon be tested in several cities. Covaclin testing has begun in Hyderabad, Patna, Kanchipuram, Rohtak and now Delhi. The vaccine will then be tested in Nagpur, Bhubaneswar, Belgaum, Gorakhpur, Kanpur, Goa and Visakhapatnam.